SPY339.39-6.39 -1.85%
DIA277.00-6.34 -2.24%
IXIC11,358.94-189.35 -1.64%

Morgan Stanley Maintains Equal-Weight on Alexion Pharmaceuticals, Raises Price Target to $121

Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $120 to $121.

· 10/13/2020 08:15
Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $120 to $121.